Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

NCT04189679 · clinicaltrials.gov ↗

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

OTHER: Immune signature in serum associated to the metabolic signature
GENETIC: Meta-genomic signature of intestinal flora

Sponsor

University Hospital, Grenoble